Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease.

Dubash, S, Marianayagam, T, Tinazzi, I et al. (12 more authors) (2018) Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease. Rheumatology, Key 26. ISSN 1462-0324

Abstract

Metadata

Authors/Creators:
  • Dubash, S
  • Marianayagam, T
  • Tinazzi, I
  • Al-Araimi, T
  • Pagnoux, C
  • Weizman, AV
  • Richette, P
  • Tran Minh, M-L
  • Allez, M
  • Singh, A
  • Ciccia, F
  • Hamlin, J
  • Tan, AL https://orcid.org/0000-0002-9158-7243
  • Marzo-Ortega, H
  • McGonagle, D
Copyright, Publisher and Additional Information: Copyright © 2018, Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record, Dubash, S, Marianayagam, T, Tinazzi, I et al. (12 more authors) (2018) Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease. Rheumatology, Key 26 is available online at: https://doi.org/10.1093/rheumatology/key267
Keywords: vedolizumab, α4β7 integrin, Crohn’s, ulcerative colitis, spondyloarthritis, spondylarthritis, ankylosing spondylitis, axial SpA, enthesitis, mucosal vascular addressin cell adhesion molecule-1 (MADCAM-1)
Dates:
  • Published: 10 September 2018
  • Accepted: 19 July 2018
  • Published (online): 10 September 2018
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 07 Nov 2018 14:47
Last Modified: 10 Sep 2019 00:39
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/key267

Share / Export

Statistics